The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SMAD4 loss in colorectal cancer: Correlation with recurrence, chemoresistance, and immune infiltrate.
 
Isaac Wasserman
No Relationships to Disclose
 
Lik Hang Lee
No Relationships to Disclose
 
Jinru Shia
No Relationships to Disclose
 
Chao Wu
No Relationships to Disclose
 
Xi Chen
No Relationships to Disclose
 
Jose G. Guillem
No Relationships to Disclose
 
Philip Paty
No Relationships to Disclose
 
Martin R. Weiser
No Relationships to Disclose
 
Garrett Michael Nash
No Relationships to Disclose
 
Larissa K. F. Temple
No Relationships to Disclose
 
Leonard Saltz
Consulting or Advisory Role - Abbvie; Lilly; McNeil PPC (I); Roche/Genentech
Research Funding - Taiho Pharmaceutical
 
Rona D. Yaeger
No Relationships to Disclose
 
Afsar Barlas
No Relationships to Disclose
 
Katia O Manova-Todorova
No Relationships to Disclose
 
Efsevia Vakiani
No Relationships to Disclose
 
Arthur E Elghouayel
No Relationships to Disclose
 
Nancy E. Kemeny
No Relationships to Disclose
 
Julio Garcia-Aguilar
No Relationships to Disclose
 
Charles L. Sawyers
Leadership - Novartis
Stock and Other Ownership Interests - Agios; BeiGene; Blueprint Medicines; Novartis; ORIC Pharmaceuticals
Consulting or Advisory Role - Agios; BeiGene; Blueprint Medicines; Novartis; ORIC Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Xtandi
 
Jesse Joshua Smith
No Relationships to Disclose